Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements
Search Results:
1-15 of 54514 results
Woodley Equipment to Attend ICSE Exhibition, Barcelona
Woodley Equipment is attending ICSE Exhibition taking place on 4th to 6th October 2016 at Fira de Barcelona Gran Via, Barcelona, Spain.
Contract Research & Services > Clinical Trials > Press Releases
Pharmaron enters into non-binding heads of terms with MSD over Hoddesdon UK site
Pharmaron has entered into a non-binding Heads of Terms (HoTs) with Merck Sharp & Dohme Limited (MSD) for the sale of the Hoddesdon UK site which includes MSD’s process development and research facility.
Production & Manufacturing > Manufacturing > News
ERYTECH completes patient enrollment in phase 2 trial of eryaspase for pancreatic cancer
ERYTECH Pharma has enrolled final patient in its phase 2 trial of eryaspase, also known as ERY-ASP or GRASPA, for the treatment of pancreatic cancer.
Contract Research & Services > Clinical Trials > News
BioLineRx in-licenses novel treatment for liver failure conditions
BioLineRx has signed an exclusive, worldwide agreement with BGN Technologies, the Technology Transfer Company of Ben-Gurion University, and Hadasit, the Technology Transfer Company of Hadassah Medical Organization, for the in-licensing of a novel treatment for various liver failure conditions such as end-stage liver disease (ESLD) and for conditions potentially leading to liver failure such as non-alcoholic steatohepatitis (NASH).
Contract Research & Services > Contract Services > News
Janssen Biotech files US regulatory application for Sirukumab in rheumatoid arthritis
By PBR Staff Writer
Janssen Biotech is seeking approval for sirukumab in the US to treat adults with moderately to severely active rheumatoid arthritis (RA).
Production & Manufacturing > Process & Production > News
FDA approves expanded use of Novartis’ Ilaris to treat three rare periodic fever syndromes
By PBR Staff Writer
Novartis has secured three new approvals from the US Food and Drug Administration (FDA) for the expanded use of Ilaris (canakinumab) to treat three rare types of Periodic Fever Syndromes.
Regulatory Affairs > News
Ligand Pharmaceuticals licensing deals with Seelos Therapeutics for four programs
Ligand Pharmaceuticals has licensed rights to four programs to Seelos Therapeutics a newly formed biopharmaceutical firm focused on central nervous system (CNS), respiratory and other disorders.
Contract Research & Services > Contract Services > News
Evotec forms research collaboration with Inserm Transfert in oncology
Evotec has entered into a research collaboration with Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research (Inserm).
Contract Research & Services > Contract Research > News
Sanaria's preventative vaccine for malaria gets FDA fast track designation
The US Food and Drug Administration (FDA) has granted Fast Track designation for Sanaria's preventative vaccine for malaria, Sanaria PfSPZ Vaccine.
Regulatory Affairs > News
UK’s NICE supports restricted use of Alexion Pharmaceuticals' Strensiq
By PBR Staff Writer
The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Alexion Pharmaceuticals’ Strensiq (asfotase alfa) drug to treat rare inherited bone disorder in children.
Drug Research > Drug Delivery > News
Teva's second phase III study of SD-809 in TD shows statistically significant results
By PBR Staff Writer
A phase III clinical trial, AIM-TD, evaluating Teva Pharmaceutical Industries' SD-809 (deutetrabenazine) to treat tardive dyskinesia (TD) demonstrated a statistically valid treatment benefit.
Contract Research & Services > Clinical Trials > News
FDA approves Janssen’s new type 2 diabetes combination therapy
By PBR Staff Writer
Janssen Pharmaceuticals has secured approval from the US Food and Drug Administration (FDA) for a fixed-dose combination therapy to treat adults with type 2 diabetes.
Regulatory Affairs > News
Takeda, Affilogic partner to develop CNS therapies
Takeda Pharmaceutical Company and Affilogic have entered into a research collaboration to explore using Affilogic’s Nanofitins platform in therapies targeting the central nervous system (CNS).
Contract Research & Services > Contract Research > News

PBR Supplier Recommendations

Life Chemicals - Specialists in Development, Production and Sales of Novel Screen Compounds
Life Chemicals Inc, established in 2004, specialises in development, production and sales of novel screening compounds for HTS, targeted screening libraries and core building blocks for drug discovery projects.... Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
Hybrigenics Services - Protein Interactions Expert
Who else knows your protein better than you? Who else knows proteins interactions better than us?... Contract Research & Services > Contract Research > Suppliers
SchuF Valves- Innovative, custom valve solutions for the pharmaceutical industry
The SchuF group, inventor of the bottom outlet valve, manufactures custom, flush-mounted valves that eliminate dead space in the reactor outlet nozzle. The main features and benefits of SchuF valves include the following;... Suppliers
Bruker Optics - Fourier Transform Infrared, Near Infrared and Raman Spectrometers
Bruker Optics is the leading manufacturer and worldwide supplier of fourier transform Infrared (FTIR), near infrared and raman spectrometers for a number of industries and applications, such as pharmaceutical and life sciences.... Automation > Laboratory Instrumentation > Suppliers
LABORATORIOS INIBSA - Pharmaceutical Contract Manufacturing Company
LABORATORIOS INIBSA is a pharmaceutical contract manufacturing company. We have more than 60 years' experience and belong to the INIBSA GROUP. INIBISA supplies products and services to Biotools, Inibsa Dental and Inibsa Hospital, as well as other pharmaceutical companies through our contract manufacturing division. From our facilities in Lliçà de Vall, 20km from Barcelona LABORATORIOS INIBSA currently supplies more than 50 countries worldwide.... Production & Manufacturing > Manufacturing > Suppliers
See more

PBR White Paper Recommendations

Going with the Flow: Malvern Instruments' Basic Introduction to Rheology By Malvern Instruments
Rheology concerns itself with materials that have aspects of both solids and liquids, and researches the flow and deformation of matter. Malvern Instruments explores this study, and reveals its fundamental in relation to force, deformation and time.... White Papers Malvern Instruments Shares its Buyer's Guide to Protein Stability Measurement Platforms By Malvern Instruments
As a leader in best practices during biopharmaceutical development, Malvern Instruments sheds light on effective protein stability analysis technologies for the biopharmaceutical industry.... White Papers Reliable, Long-range Wireless Sensors for Environmental Monitoring By Vaisala pbr
The Vaisala viewLinc Monitoring System tracks environmental conditions wirelessly using Vaisala’s VaiNet wireless devices based on LoRa™* technology. By using a chirp spread spectrum (CSS)* wireless protocol, VaiNet provides robust communication that is extremely reliable over long distances and under harsh, complex and obstructed conditions.... Contract Research & Services > Clinical Trials > White Papers Five Ways That the Mastersizer 3000 Saves you Money By Malvern Instruments
To earn its place in today’s busy analytical laboratories, an instrument must meet certain practical criteria, and stand-up to rigorous economic evaluation. For labs that need particle sizing, laser diffraction systems are typically the technology of choice; delivering accurate and reliable information for the broadest range of sample types. Here, we look at how the Mastersizer 3000, the market leading laboratory particle size analyzer from Malvern Instruments, can save you time, money and resources, and ultimately deliver a healthy return on investment.... White Papers Time to Spec up? Top Five Reasons to Replace a Viscometer with a Rheomete By Malvern Instruments
Is your viscometer approaching the end of its life? Are you starting to feel that your trial and error, ‘rheology-light’ approach to formulation is becoming dated? Or are there longstanding product performance issues that you’re failing to gain traction with, where you suspect rheology may hold the answer?... White Papers See more
1-15 of 54514 results